| |
 |
|
|
|
Genizon BioSciences (formerly Galileo Genomics) is changing medicine and drug development through the discovery of disease genes, drug targets and disease-associated biomarkers. By mapping common human diseases, Genizon's research will lead to the development of innovative new drugs and diagnostics that treat the source of these diseases rather than just the symptoms. Genizon has experienced unprecedented success in the discovery of genes unequivocally associated with common diseases and the development of GeneMaps. Genizon recently acquired a novel technology for fast and inexpensive whole genome resequencing from Global Genomics, a spin-out from the Karolinska Institute.
www.genizon.com
|
|
| |
|
|
|
